(PHAT)
NMS – Real Time Price. Currency in USD
10.58
-0.21 (-1.95%)
At close: Mar 27, 2026, 4:00 PM EDT
10.58
0.00 (0.00%)
After-hours: Mar 27, 2026, 4:34 PM EDT
Get all premium features to the best stock analysis tool
NMS – Real Time Price. Currency in USD
10.58
-0.21 (-1.95%)
At close: Mar 27, 2026, 4:00 PM EDT
10.58
0.00 (0.00%)
After-hours: Mar 27, 2026, 4:34 PM EDT
Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults; and VOQUEZNA Triple Pak and VOQUEZNA Dual Pak that have completed Phase III clinical trials for treating Helicobacter pylori, as well as VOQUEZNA and vonoprazan for the treatment of heartburn associated with non-erosive GERD and eosinophilic esophagitis in adults and adolescents. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
| Name | Position |
|---|---|
| Dr. Azmi Nabulsi M.D., M.P.H. | Co-Founder |
| Mr. Bill Aprea J.D. | Senior VP, Chief Compliance Officer & Deputy Chief Legal Officer |
| Mr. David A. Socks | Co-Founder |
| Mr. Eric Sciorilli | Director of Business Development & Investor Relations |
| Mr. Jonathan Bentley | Senior VP and Head of Sales, Operations & Training |
| Mr. Paul Cocja | Chief People Officer |
| Mr. Robert Breedlove | VP of Finance & Principal Accounting Officer |
| Date | Type | Document |
|---|---|---|
| 2025-11-04 | 8-K | d20656d8k.htm |
| 2025-10-30 | 10-Q | phat-20250930.htm |
| 2025-10-27 | 8-K | d62248d8k.htm |
| 2025-10-06 | 8-K | d76139d8k.htm |
| 2025-08-07 | 10-Q | phat-20250630.htm |
| 2025-06-16 | 8-K | d924090d8k.htm |
| 2025-06-09 | 8-K | d95460d8k.htm |
| 2025-06-06 | 8-K | d941196d8k.htm |
| 2025-05-01 | 10-Q | phat-20250331.htm |
| 2025-04-23 | DEFA14A | phat-20250422.htm |
| Mr. Sanjeev Narula |
| Chief Financial & Business Officer |
| Mr. Steven L. Basta M.B.A. | CEO, President & Director |
| Ms. Anne Marie Cook Esq., J.D. | Chief Legal Officer & Corporate Secretary |